v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net increase (decrease) in net assets resulting from operations $ 34,732 $ 304,851
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change in unrealized (appreciation) depreciation on investments 290,994 49,073
Net change in unrealized (appreciation) depreciation on derivative instruments (1,166) 5,047
Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies 883 (1,304)
Net realized (gain) loss on investments 40,286 (7,295)
Net change due to hedging activity 541 (1,120)
Net realized (gain) loss on foreign currency transactions (8,466) 0
Net accretion of discount and amortization of premium (24,585) (27,554)
Payment-in-kind interest capitalized (42,658) (42,963)
Amortization of deferred financing costs 3,408 2,850
Amortization of original issue discount and debt issuance costs (including premiums and discounts) 8,450 7,085
Purchases of investments (636,615) (1,219,695)
Proceeds from sale of investments and principal repayments 1,204,877 1,163,365
Changes in operating assets and liabilities:    
Interest receivable (2,260) 7,344
Receivable for investments (21,993) (20,438)
Derivative instruments, net (21,838) 4,380
Receivable from broker 9,449 (6,263)
Payable for investments 7,470 (16,937)
Due to affiliates 546 (1,466)
Management fees payable (859) 2,295
Income based incentive fees payable (24,710) (3,990)
Capital gains based incentive fees payable 0 0
Interest payable 820 11,216
Accrued expenses and other liabilities (7,086) (4,877)
Net cash provided by (used in) operating activities 810,220 203,604
Cash flows from financing activities:    
Borrowings on debt 2,337,299 1,062,898
Repayments on debt (2,819,129) (1,134,031)
Deferred financing costs paid (3,430) (430)
Debt issuance costs paid (2,165) (2,372)
Dividends paid in cash (340,649) (335,662)
Proceeds from issuance of Common Shares, net of offering and underwriting costs 0 247,854
Net cash provided by (used in) financing activities (828,074) (161,743)
Net increase (decrease) in cash and cash equivalents (17,854) 41,861
Effect of foreign exchange rate changes on cash and cash equivalents (4,596) 2,211
Cash and cash equivalents (including restricted cash), beginning of period 289,605 229,606
Cash and cash equivalents (including restricted cash), end of period 267,155 273,678
Supplemental information and non-cash activities:    
Interest paid during the period 188,307 165,186
Distribution payable 179,142 177,007
Reinvestment of distributions during the period 16,823 10,510
Accrued but unpaid debt issuance costs 3,400 250
Receivable for shares sold 0 5,393
Excise and other taxes paid $ 16,022 $ 15,066